Evaluation and developement of therapies

Subproject 10:

Long term effects of myeloablative radiochemotherapy with consecutive autologous peripheral blood stem cell transplantation in patients with malignant lymphomas – frequency and early diagnosis of secondary haematological neoplasias

Project leader: PD Dr. M. Dreyling, Prof. Dr. W. Hiddemann (University of Munich Hospital)

Subproject 11:

Development of strategies for immunological and genetherapeutic vaccines for malignant lymphomas

Project leader: Prof. Dr. M. Pfreundschuh (Saarland University Hospital)

Subproject 13:

Improvement of the infrastructure for the analysis of biologic risk factors in malignant lymphomas

Project leader: PD Dr. M. Bentz (University Ulm), PD Dr. M. Dreyling (University of Munich Hospital)